Amelioration of inflammation, angiogenesis and CTGF expression in an arthritis model by a TSP1-derived peptide treatment

Journal of Cellular Physiology

Volumn 211, Issue 2, 2007, Pages 504-512

  Rico, Mario C ^a,b   Castaneda, Julian L ^a   Manns, Joanne M ^a   Uknis, Audrey B ^a   Sainz, Irma M ^a   Safadi, Fayez F ^a   Popoff, Steve N ^a   Dela Cadena, Raul A ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University School of Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; PEPTIDE DERIVATIVE; PEPTIDOGLYCAN POLYSACCHARIDE; THROMBOSPONDIN 1;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANKLE; ARTHRITIS; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION REGULATION; GRANULOMA; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; JOINT; LEUKOCYTE MIGRATION; LEWIS RAT; LIVER; MORPHOMETRICS; NEOVASCULARIZATION (PATHOLOGY); NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SPLEEN; TREATMENT OUTCOME;

ANIMALS; ANKLE JOINT; ANTI-INFLAMMATORY AGENTS; ANTIRHEUMATIC AGENTS; ARTHRITIS, EXPERIMENTAL; CARTILAGE, ARTICULAR; FEMALE; GENE EXPRESSION; GRANULOMA; HEPATOMEGALY; IMMEDIATE-EARLY PROTEINS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKOCYTES; MACROPHAGES; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDES; PEPTIDOGLYCAN; POLYSACCHARIDES; RATS; RATS, INBRED LEW; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPLENOMEGALY; THROMBOSPONDIN 1; TIME FACTORS;

ANIMALIA; RATTUS;

EID: 34147211504     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20958     Document Type: Article

References (39)

1. Babic AM, Chen CC, Lau LF. 1999. Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivo. Mol Cell Biol 19:2958-2966.
2. Barr AE, Safadi FF, Gorzelany I, Amin M, Popoff SN, Barbe MF. 2003. Repetitive, negligible force reaching in rats induces pathological overloading of upper extremity bones. J Bone Miner Res 18:2023-2032.
3. Bork P. 1993. The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett 327:125-130.
4. Bucala R, Lolis E. 2005. Macrophage migration inhibitory factor: A critical component of autoimmune inflammatory diseases. Drug News Perspect 18:417-426.
5. Chambers RC, Leoni P, Blanc-Brude OP, Wembridge DE, Laurent GJ. 2000. Thrombin is a potent inducer of connective tissue growth factor production via proteolytic activation of protease-activated receptor-1. J Biol Chem 275:35584-35591.
6. Crawford SE, Stellmach V, Murphy-Ullrich JE, Ribeiro SM, Lawler J, Hynes RO, Boivin GP, Bouck N. 1998. Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell 93:1159-1170.
7. DeLa Cadena RA, Laskin KJ, Pixley RA, Sartor RB, Schwab JH, Back N, Bedi GS, Fisher RS, Colman RW. 1991. Role of kallikrein-kinin system in pathogenesis of bacterial cell wall-induced inflammation. Am J Physiol 260:G213-G219.
8. Dela Cadena RA, Stadnicki A, Uknis AB, Sartor RB, Kettner CA, Adam A, Colman RW. 1995. Inhibition of plasma kallikrein prevents peptidoglycan-induced arthritis in the Lewis rat FASEB J 9:446-452.
9. Esser RE, Anderle SK, Chetty C, Stimpson SA, Cromartie WJ, Schwab JH. 1986. Comparison of inflammatory reactions induced by intraarticular injection of bacterial cell wall polymers. Am J Pathol 122:323-334.
10. Gotis-Graham I, Hogg PJ, McNeil HP. 1997. Significant correlation between thrombospondin 1 and serine proteinase expression in rheumatoid synovium. Arthritis Rheum 40:1780-1787.
11. Hogg PJ, Jimenez BM, Chesterman CN. 1994. Identification of possible inhibitory reactive centers in thrombospondin 1 that may bind cathepsin G and neutrophil elastase. Biochemistry 33:6531-6537.
12. Igarashi A, Okochi H, Bradham DM, Grotendorst GR. 1993. Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell 4:637-645.
13. Isordia-Salas I, Manns JM, Sainz I, Parekh H, DeLa Cadena RA. 2005. Thromsbospondin-1 binds to the heavy chain of elastase activated coagulation factor V (FVaHNE) and enhances thrombin generation on the surface of a promyelocytic cell line. Thromb Res 116:533-543.
14. Ivkovic S, Yoon BS, Popoff SN, Safadi FF, Libuda DE, Stephenson RC, Daluiski A, Lyons KM. 2003. Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development 130:2779-2791.
15. Kannan K, Ortmann RA, Kimpel D. 2005. Animal models of rheumatoid arthritis and their relevance to human disease. Pathophysiology 12:167-181.
16. Kinne RW, Brauer R, Stuhlmuller B, Palombo-Kinne E, Burmester GR. 2000. Macrophages in rheumatoid arthritis. Arthritis Res 2:189-202.
17. Lainer DT, Brahn E. 2005. New antiangiogenic strategies for the treatment of proliferative synovitis. Expert Opin Investig Drugs 14:1-17.
18. Lawler J. 2002. Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth. J Cell Mol Med 6:1-12.
19. Leask A. 2004. Transcriptional profiling of the scleroderma fibroblast reveals a potential role for connective tissue growth factor (CTGF) in pathological fibrosis. Keio J Med 53:74-77.
20. Majluf-Cruz A, Manns JM, Uknis AB, Yang X, Colman RW, Harris RB, Frazier W, Lawler J, DeLa Cadena RA. 2000. Residues F16-G33 and A784-N823 within platelet thrombospondin-1 play a major role in binding human neutrophils: Evaluation by two novel binding assays. J Lab Clin Med 136:292-302.
21. Manns JM, Uknis AB, Rico MC, Agelan A, Castaneda J, Arango I, Barbe MF, Safadi FF, Popoff SN, DeLa Cadena RA. 2006. A peptide from thrombospondin I modulates experimental erosive arthritis by regulating connective tissue growth factor. Arthritis Rheum 54:2415-2422.
22. Mansfield PJ, Suchard SJ. 1994. Thrombospondin promotes chemotaxis and haptotaxis of human peripheral blood monocytes. J Immunol 153:4219-4229.
23. Maruotti N, Cantatore FP, Crivellato E, Vacca A, Ribatti D. 2006. Angiogenesis in rheumatoid arthritis. Histol Histopathol 21:557-566.
24. Mishiro T, Nakano S, Takahara S, Miki M, Nakamura Y, Yasuoka S, Nikawa T, Yasui N. 2004. Relationship between cathepsin B and thrombin in rheumatoid arthritis. J Rheumatol 31:1265-1273.
25. Moreland LW, Baumgartner SW, Schiff MH, Tindall EA, Fleischmann RM, Weaver AL, Ettlinger RE, Cohen S, Koopman WJ, Mohler K, Widmer MB, Blosch CM. 1997. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med 337:141-147.
26. Moussad EE, Brigstock DR. 2000. Connective tissue growth factor: What's in a name? Mol Genet Metab 71:276-292.
27. Rachfal AW, Brigstock DR. 2003. Connective tissue growth factor (CTGF/CCN2) in hepatic fibrosis. Hepatol Res 26:1-9.
28. Roccaro AM, Russo F, Cirulli T, Di Pietro G, Vacca A, Dammacco F. 2005. Antiangiogenesis for rheumatoid arthritis. Curr Drug Targets Inflamm Allergy 4:27-30.
29. Safadi FF, Xu J, Smock SL, Kanaan RA, Selim AH, Odgren PR, Marks SC, Jr., Owen TA, Popoff SN. 2003. Expression of connective tissue growth factor in bone: Its role in osteoblast proliferation and differentiation in vitro and bone formation in vivo. J Cell Physiol 196:51-62.
30. Sartor RB, DeLa Cadena RA, Green KD, Stadnicki A, Davis SW, Schwab JH, Adam AA, Raymond P, Colman RW. 1996. Selective kallikrein-kinin system activation in inbred rats differentially susceptible to granulomatous enterocolitis. Gastroenteroiogy 110:1467-1481.
31. Sato S, Nagaoka T, Hasegawa M, Tamatani T, Nakanishi T, Takigawa M, Takehara K. 2000. Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: Association with extent of skin sclerosis and severity of pulmonary fibrosis. J Rheumatol 27:149-154.
32. Schultz-Cherry S, Lawler J, Murphy-Ullrich JE. 1994. The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-beta. J Biol Chem 269:26783-26788.
33. So AK, Varisco PA, Kemkes-Matthes B, Herkenne-Morard C, Chobaz-Peclat V, Gerster JC, Busso N. 2003. Arthritis is linked to local and systemic activation of coagulation and fibrinolysis pathways. J Thromb Haemost 1:2510-2515.
34. Stimpson SA, Esser RE, Carter PB, Sartor RB, Cromartie WJ, Schwab JH. 1987. Lipopolysaccharide induces recurrence of arthritis in rat joints previously injured by peptidoglycan-polysaccharide. J Exp Med 165:1688-1702.
35. Stuhlmuller B, Ungethum U, Scholze S, Martinez L, Backhaus M, Kraetsch HG, Kinne RW, Burmester GR. 2000. Identification of known and novel genes in activated monocytes from patients with rheumatoid arthritis. Arthritis Rheum 43:775-790.
36. Taylor PC, Sivakumar B. 2005. Hypoxia and angiogenesis in rheumatoid arthritis. Curr Opin Rheumatol 17:293-298.
37. Vallejo AN, Mugge LO, Klimiuk PA, Weyand CM, Goronzy JJ. 2000. Central role of thrombospondin-1 in the activation and clonal expansion of inflammatory T cells, J Immunol 164:2947-2954.
38. Yamamoto T, Sawada Y, Katayama I, Nishioka K. 2005. Nodular scleroderma: Increased expression of connective tissue growth factor. Dermatology 211:218-223.
39. Zhang X, Rimpilainen M, Hoffmann B, Simelyte E, Aho H, Toivanen P. 2001. Experimental chronic arthritis and granulomatous inflammation induced by bifidobacterium cell walls. Scand J Immunol 54:171-179.